Niek N. Sanders

Prof. Dr. Niek N. Sanders

Laboratory of Gene Therapy, Ghent University, Heidestraat 19, 9820 Merelbeke, Belgium
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
OAOliwia Andries
Oliwia Andries
SCSéan Mc Cafferty
Séan Mc Cafferty
SSStefaan C. De Smedt
Stefaan C. De Smedt
RWRon Weiss
Ron Weiss
NSNiek N. Sanders
Niek N. Sanders
TKTasuku Kitada
Tasuku Kitada

1 March 2010 in Molecular Therapy
Verified
Journal Article
Open access
PDF file
DVDries Vercauteren
Dries Vercauteren
Roosmarijn VandenbrouckeRoosmarijn Vandenbroucke
Roosmarijn Vandenbroucke
AJArwyn T. Jones
Arwyn T. Jones
JRJoanna Rejman
Joanna Rejman
JDJoseph Demeester
Joseph Demeester
KBKevin Braeckmans
Kevin Braeckmans
Nonviral gene complexes can enter mammalian cells through different endocytic pathways. For efficient optimization of the gene carrier it is important to profile its cellular uptake, because this largely determines its intracellular processing and subsequent transfection efficiency. Most of the current information on uptake of these gene-delivery vehicles is based on data following the use of chemical inhibitors of endocytic pathways. Here, we have performed a detailed characterization of four commonly used endocytosis inhibitors [chlorpromazine, genistein, methyl-β-cyclodextrin (MβCD), and potassium depletion] on cell viability and endocytosis in five well-described cell lines. We found that chlorpromazine and to a lesser extent MβCD significantly decreased cell viability of some cell lines even after short incubation periods and at concentrations that are routinely used to inhibit endocytosis. Through analyzing the uptake and subcellular distribution of two fluorescent endocytic probes transferrin and lactosylceramide (LacCer) that are reported to enter cells via clathrin-dependent (CDE) and clathrin-independent (CIE) mechanisms, respectively, we showed poor specificity of these agents for inhibiting distinct endocytic pathways. Finally, we demonstrate that any inhibitory effects are highly cell line dependent. Overall, the data question the significance of performing endocytosis studies with these agents in the absence of very stringent controls.

21 March 2006 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
BGB. G. De Geest
B. G. De Geest
Roosmarijn VandenbrouckeRoosmarijn Vandenbroucke
Roosmarijn Vandenbroucke
AGA. M. Guenther
A. M. Guenther
GSG. B. Sukhorukov
G. B. Sukhorukov
WHW. E. Hennink
W. E. Hennink
SSS. C. De Smedt
S. C. De Smedt

1 January 2010 in Molecular Therapy
Verified
Journal Article
Open access
ILIne Lentacker
Ine Lentacker
BGBart Geers
Bart Geers
JDJoseph Demeester
Joseph Demeester
SSStefaan De Smedt
Stefaan De Smedt
NSNiek N. Sanders
Niek N. Sanders
Drug delivery with microbubbles and ultrasound is gaining more and more attention in the drug delivery field due to its noninvasiveness, local applicability, and proven safety in ultrasonic imaging techniques. In this article, we tried to improve the cytotoxicity of doxorubicin (DOX)-containing liposomes by preparing DOX-liposome-containing microbubbles for drug delivery with therapeutic ultrasound. In this way, the DOX release and uptake can be restricted to ultrasound-treated areas. Compared to DOX-liposomes, DOX-loaded microbubbles killed at least two times more melanoma cells after exposure to ultrasound. After treatment of the melanoma cells with DOX-liposome-loaded microbubbles and ultrasound, DOX was mainly present in the nuclei of the cancer cells, whereas it was mainly detected in the cytoplasm of cells treated with DOX-liposomes. Exposure of cells to DOX-liposome-loaded microbubbles and ultrasound caused an almost instantaneous cellular entry of the DOX. At least two mechanisms were identified that explain the fast uptake of DOX and the superior cell killing of DOX-liposome-loaded microbubbles and ultrasound. First, exposure of DOX-liposome-loaded microbubbles to ultrasound results in the release of free DOX that is more cytotoxic than DOX-liposomes. Second, the cellular entry of the released DOX is facilitated due to sonoporation of the cell membranes. The in vitro results shown in this article indicate that DOX-liposome-loaded microbubbles could be a very interesting tool to obtain an efficient ultrasound-controlled DOX delivery in vivo.

1 October 2003 in Biophysical Journal
Verified
Journal Article
Closed access
KBKevin Braeckmans
Kevin Braeckmans
LPLiesbeth Peeters
Liesbeth Peeters
NSNiek N. Sanders
Niek N. Sanders
SSStefaan De Smedt
Stefaan De Smedt
JDJoseph Demeester
Joseph Demeester

1 April 2009 in Soft Matter
Verified
Journal Article
Closed access
PDF file
ILIne Lentacker
Ine Lentacker
SSStefaan De Smedt
Stefaan De Smedt
NSNiek N. Sanders
Niek N. Sanders
Ultrasound imaging is widely used in both diagnosis of diseases and pregnancy follow-up. As ultrasound imaging is a harmless, cheap and portable technique, ultrasound guided drug delivery is gaining more and more attention in the drug delivery field. To be effective, in most cases, ultrasonic drug delivery makes use of microbubbles. This highlight describes why it is attractive to load the microbubbles with drugs and discusses recent attempts made in the design of drug loaded microbubbles.